Repurposing the Antiemetic Metoclopramide As an Antiviral Against Dengue Virus Infection in Neuronal Cells

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2021 Feb 26

PMID 33634036

Citations 6

Authors

Ting-Jing Shen

Vu Thi Hanh

Thai Quoc Nguyen

Ming-Kai Jhan

Min-Ru Ho

Chiou-Feng Lin

Affiliations

Soon will be listed here.

Abstract

Dengue virus (DENV) is transmitted by Aedes mosquitoes to humans and is a threat worldwide. No effective new drugs have been used for anti-dengue treatment, and repurposing drugs is an alternative approach to treat this condition. Dopamine 2 receptor (D2R) is a host receptor positively associated with DENV infection. Metoclopramide (MCP), a D2R antagonist clinically used to control vomiting and nausea in patients with DENV infection, was putatively examined for inhibition of DENV infection by targeting D2R. In the mouse neural cell line Neuro-2a with D2R expression, a plaque assay demonstrated the antiviral efficacy of MCP treatment. However, in the cell line BHK-21, which did not express D2R, MCP treatment caused no further inhibition of DENV infection. Either MCP treatment or exogenous administration of a neutralizing D2R antibody blocked DENV binding. Treatment with MCP also reduced DENV dsRNA replication and DENV-induced neuronal cell cytotoxicity . An study demonstrated the antiviral effect of MCP against DENV-induced CNS neuropathy and mortality. These results showed that repurposing the D2R-targeting antiemetic MCP is a potential therapeutic strategy against DENV infection.

Citing Articles

Quantification of the interaction forces between dengue virus and dopamine type-2 receptor using optical tweezers.

Arifin J, Tsai B, Chen C, Chu L, Lin Y, Lee C Virol J. 2024; 21(1):215.

PMID: 39261951 PMC: 11391641. DOI: 10.1186/s12985-024-02487-8.

Anti-Dengue: A Machine Learning-Assisted Prediction of Small Molecule Antivirals against Dengue Virus and Implications in Drug Repurposing.

Gautam S, Thakur A, Rajput A, Kumar M Viruses. 2024; 16(1).

PMID: 38257744 PMC: 10818795. DOI: 10.3390/v16010045.

Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview.

Diani E, Lagni A, Lotti V, Tonon E, Cecchetto R, Gibellini D Microorganisms. 2023; 11(10).

PMID: 37894085 PMC: 10608811. DOI: 10.3390/microorganisms11102427.

A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2.

Punekar M, Kasabe B, Patil P, Kakade M, Parashar D, Alagarasu K Viruses. 2022; 14(10).

PMID: 36298705 PMC: 9609047. DOI: 10.3390/v14102150.

Inhibition of dengue virus infection by trifluoperazine.

Piccini L, Castilla V, Damonte E Arch Virol. 2022; 167(11):2203-2212.

PMID: 35920983 PMC: 9362669. DOI: 10.1007/s00705-022-05555-y.

References

Yu I, Zhang W, Holdaway H, Li L, Kostyuchenko V, Chipman P . Structure of the immature dengue virus at low pH primes proteolytic maturation. Science. 2008; 319(5871):1834-7. DOI: 10.1126/science.1153264. View

Cruz-Oliveira C, Freire J, Conceicao T, Higa L, Castanho M, Da Poian A . Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev. 2015; 39(2):155-70. DOI: 10.1093/femsre/fuu004. View

Leong A, Wong K, Leong T, Tan P, Wannakrairot P . The pathology of dengue hemorrhagic fever. Semin Diagn Pathol. 2007; 24(4):227-36. DOI: 10.1053/j.semdp.2007.07.002. View

Welliver M . Dopamine antagonists for nausea and vomiting: special considerations. Gastroenterol Nurs. 2014; 37(5):361-4. DOI: 10.1097/SGA.0000000000000068. View

Simanjuntak Y, Liang J, Lee Y, Lin Y . Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells. Front Microbiol. 2017; 8:651. PMC: 5387065. DOI: 10.3389/fmicb.2017.00651. View

Athavale A, Athavale T, Roberts D . Antiemetic drugs: what to prescribe and when. Aust Prescr. 2020; 43(2):49-56. PMC: 7186277. DOI: 10.18773/austprescr.2020.011. View

Ito K, Haga T, Lameh J, Sadee W . Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem. 1999; 260(1):112-9. DOI: 10.1046/j.1432-1327.1999.00125.x. View

Welsch S, Miller S, Romero-Brey I, Merz A, Bleck C, Walther P . Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe. 2009; 5(4):365-75. PMC: 7103389. DOI: 10.1016/j.chom.2009.03.007. View

de la Guardia C, Lleonart R . Progress in the identification of dengue virus entry/fusion inhibitors. Biomed Res Int. 2014; 2014:825039. PMC: 4135166. DOI: 10.1155/2014/825039. View

10.

Gaskill P, Calderon T, Luers A, Eugenin E, Javitch J, Berman J . Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol. 2009; 175(3):1148-59. PMC: 2731133. DOI: 10.2353/ajpath.2009.081067. View

11.

Hadinegoro S . The revised WHO dengue case classification: does the system need to be modified?. Paediatr Int Child Health. 2012; 32 Suppl 1:33-8. PMC: 3381438. DOI: 10.1179/2046904712Z.00000000052. View

12.

van der Schaar H, Rust M, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X . Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008; 4(12):e1000244. PMC: 2592694. DOI: 10.1371/journal.ppat.1000244. View

13.

Ho M, Tsai T, Chen C, Jhan M, Tsai C, Lee Y . Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in vitro and in vivo by targeting endocytic pathways. Sci Rep. 2017; 7(1):6910. PMC: 5537343. DOI: 10.1038/s41598-017-07023-z. View

14.

Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D . Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl):S7-16. PMC: 4333201. DOI: 10.1038/nrmicro2460. View

15.

Shen T, Jhan M, Kao J, Ho M, Tsai T, Tseng P . A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease. J Vis Exp. 2019; (146). DOI: 10.3791/59132. View

16.

Sprokholt J, Kaptein T, van Hamme J, Overmars R, Gringhuis S, Geijtenbeek T . RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and T1 Differentiation. J Immunol. 2017; 198(12):4764-4771. DOI: 10.4049/jimmunol.1602121. View

17.

Aravapalli S, Lai H, Teramoto T, Alliston K, Lushington G, Ferguson E . Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. Bioorg Med Chem. 2012; 20(13):4140-8. PMC: 3563422. DOI: 10.1016/j.bmc.2012.04.055. View

18.

Milligan G, Sarathy V, Infante E, Li L, Campbell G, Beatty P . A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice. PLoS One. 2015; 10(5):e0125476. PMC: 4418603. DOI: 10.1371/journal.pone.0125476. View

19.

Acosta E, Castilla V, Damonte E . Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J Gen Virol. 2008; 89(Pt 2):474-484. DOI: 10.1099/vir.0.83357-0. View

20.

Ferguson N . Challenges and opportunities in controlling mosquito-borne infections. Nature. 2018; 559(7715):490-497. DOI: 10.1038/s41586-018-0318-5. View